| |
|
NEWS
|
June 22, 2010
MOLOGEN AG receives approval for clinical study with cell-based gene therapy against renal cancer
 press release
ad-hoc announcement
|
|
June 22, 2010
MOLOGEN AG starts phase 2 clinical study with DNA-based cancer medicine MGN1703 against colorectal cancer
more
|
NEWSLETTER |
| To subscribe to our Newsletter please
click here |
|
|
